Selected research
Industry Growth & Trends
Global Codeine Tablet Industry Growth and Trends Forecast to 2032
Market perspective
The global Codeine Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Codeine Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Codeine Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Codeine Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Codeine Tablet include TEVA, Johnson & Johnson, Novartis, Mylan, Taiji, Sanofi Aventis, Pharmaceutical Associates, Medreich and Mallinckrodt, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Codeine Tablet market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Codeine Tablet market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Codeine Tablet market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Codeine Tablet.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Codeine Tablet market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Codeine Tablet Market by Company
TEVA
Johnson & Johnson
Novartis
Mylan
Taiji
Sanofi Aventis
Pharmaceutical Associates
Medreich
Mallinckrodt
Lannett Company
Laboratoire Riva
Hikma
Cipla
Aristo Pharma GmbH
Apotex
Codeine Tablet Segment by Type
Single-ingredient Codeine
Multi-ingredient Medications
Codeine Tablet Segment by Application
Narcotic Analgesic
Antitussive
Others
Codeine Tablet Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Codeine Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Codeine Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Codeine Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Codeine Tablet manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Codeine Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single-ingredient Codeine
- Multi-ingredient Medications
Applications
- Narcotic Analgesic
- Antitussive
- Others
Companies covered
- TEVA
- Johnson & Johnson
- Novartis
- Mylan
- Taiji
- Sanofi Aventis
- Pharmaceutical Associates
- Medreich
- Mallinckrodt
- Lannett Company
- Laboratoire Riva
- Hikma
- Cipla
- Aristo Pharma GmbH
- Apotex
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Codeine Tablet Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Codeine Tablet Sales Estimates and Forecasts (2021-2032)
- 1.3 Codeine Tablet Market by Type
- 1.3.1 Single-ingredient Codeine
- 1.3.2 Multi-ingredient Medications
- 1.4 Global Codeine Tablet Market Size by Type
- 1.4.1 Global Codeine Tablet Market Size Overview by Type (2021-2032)
- 1.4.2 Global Codeine Tablet Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Codeine Tablet Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Codeine Tablet Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Codeine Tablet Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Codeine Tablet Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Codeine Tablet Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Codeine Tablet Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Codeine Tablet Industry Trends
- 2.2 Codeine Tablet Industry Drivers
- 2.3 Codeine Tablet Industry Opportunities and Challenges
- 2.4 Codeine Tablet Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Codeine Tablet Revenue (2021-2026)
- 3.2 Global Top Players by Codeine Tablet Sales (2021-2026)
- 3.3 Global Top Players by Codeine Tablet Price (2021-2026)
- 3.4 Global Codeine Tablet Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Codeine Tablet Major Company Production Sites & Headquarters
- 3.6 Global Codeine Tablet Company, Product Type & Application
- 3.7 Global Codeine Tablet Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Codeine Tablet Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Codeine Tablet Players Market Share by Revenue in 2025
- 3.8.3 2025 Codeine Tablet Tier 1, Tier 2, and Tier 3
4 Codeine Tablet Regional Status and Outlook
- 4.1 Global Codeine Tablet Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Codeine Tablet Historic Market Size by Region
- 4.2.1 Global Codeine Tablet Sales in Volume by Region (2021-2026)
- 4.2.2 Global Codeine Tablet Sales in Value by Region (2021-2026)
- 4.2.3 Global Codeine Tablet Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Codeine Tablet Forecasted Market Size by Region
- 4.3.1 Global Codeine Tablet Sales in Volume by Region (2027-2032)
- 4.3.2 Global Codeine Tablet Sales in Value by Region (2027-2032)
- 4.3.3 Global Codeine Tablet Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Codeine Tablet by Application
- 5.1 Codeine Tablet Market by Application
- 5.1.1 Narcotic Analgesic
- 5.1.2 Antitussive
- 5.1.3 Others
- 5.2 Global Codeine Tablet Market Size by Application
- 5.2.1 Global Codeine Tablet Market Size Overview by Application (2021-2032)
- 5.2.2 Global Codeine Tablet Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Codeine Tablet Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Codeine Tablet Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Codeine Tablet Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Codeine Tablet Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Codeine Tablet Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Codeine Tablet Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 TEVA
- 6.1.1 TEVA Company Information
- 6.1.2 TEVA Business Overview
- 6.1.3 TEVA Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 TEVA Codeine Tablet Product Portfolio
- 6.1.5 TEVA Recent Developments
- 6.2 Johnson & Johnson
- 6.2.1 Johnson & Johnson Company Information
- 6.2.2 Johnson & Johnson Business Overview
- 6.2.3 Johnson & Johnson Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Johnson & Johnson Codeine Tablet Product Portfolio
- 6.2.5 Johnson & Johnson Recent Developments
- 6.3 Novartis
- 6.3.1 Novartis Company Information
- 6.3.2 Novartis Business Overview
- 6.3.3 Novartis Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Novartis Codeine Tablet Product Portfolio
- 6.3.5 Novartis Recent Developments
- 6.4 Mylan
- 6.4.1 Mylan Company Information
- 6.4.2 Mylan Business Overview
- 6.4.3 Mylan Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Mylan Codeine Tablet Product Portfolio
- 6.4.5 Mylan Recent Developments
- 6.5 Taiji
- 6.5.1 Taiji Company Information
- 6.5.2 Taiji Business Overview
- 6.5.3 Taiji Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Taiji Codeine Tablet Product Portfolio
- 6.5.5 Taiji Recent Developments
- 6.6 Sanofi Aventis
- 6.6.1 Sanofi Aventis Company Information
- 6.6.2 Sanofi Aventis Business Overview
- 6.6.3 Sanofi Aventis Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Sanofi Aventis Codeine Tablet Product Portfolio
- 6.6.5 Sanofi Aventis Recent Developments
- 6.7 Pharmaceutical Associates
- 6.7.1 Pharmaceutical Associates Company Information
- 6.7.2 Pharmaceutical Associates Business Overview
- 6.7.3 Pharmaceutical Associates Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Pharmaceutical Associates Codeine Tablet Product Portfolio
- 6.7.5 Pharmaceutical Associates Recent Developments
- 6.8 Medreich
- 6.8.1 Medreich Company Information
- 6.8.2 Medreich Business Overview
- 6.8.3 Medreich Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Medreich Codeine Tablet Product Portfolio
- 6.8.5 Medreich Recent Developments
- 6.9 Mallinckrodt
- 6.9.1 Mallinckrodt Company Information
- 6.9.2 Mallinckrodt Business Overview
- 6.9.3 Mallinckrodt Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Mallinckrodt Codeine Tablet Product Portfolio
- 6.9.5 Mallinckrodt Recent Developments
- 6.10 Lannett Company
- 6.10.1 Lannett Company Company Information
- 6.10.2 Lannett Company Business Overview
- 6.10.3 Lannett Company Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Lannett Company Codeine Tablet Product Portfolio
- 6.10.5 Lannett Company Recent Developments
- 6.11 Laboratoire Riva
- 6.11.1 Laboratoire Riva Company Information
- 6.11.2 Laboratoire Riva Business Overview
- 6.11.3 Laboratoire Riva Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Laboratoire Riva Codeine Tablet Product Portfolio
- 6.11.5 Laboratoire Riva Recent Developments
- 6.12 Hikma
- 6.12.1 Hikma Company Information
- 6.12.2 Hikma Business Overview
- 6.12.3 Hikma Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Hikma Codeine Tablet Product Portfolio
- 6.12.5 Hikma Recent Developments
- 6.13 Cipla
- 6.13.1 Cipla Company Information
- 6.13.2 Cipla Business Overview
- 6.13.3 Cipla Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Cipla Codeine Tablet Product Portfolio
- 6.13.5 Cipla Recent Developments
- 6.14 Aristo Pharma GmbH
- 6.14.1 Aristo Pharma GmbH Company Information
- 6.14.2 Aristo Pharma GmbH Business Overview
- 6.14.3 Aristo Pharma GmbH Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Aristo Pharma GmbH Codeine Tablet Product Portfolio
- 6.14.5 Aristo Pharma GmbH Recent Developments
- 6.15 Apotex
- 6.15.1 Apotex Company Information
- 6.15.2 Apotex Business Overview
- 6.15.3 Apotex Codeine Tablet Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Apotex Codeine Tablet Product Portfolio
- 6.15.5 Apotex Recent Developments
7 North America by Country
- 7.1 North America Codeine Tablet Sales by Country
- 7.1.1 North America Codeine Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Codeine Tablet Sales by Country (2021-2026)
- 7.1.3 North America Codeine Tablet Sales Forecast by Country (2027-2032)
- 7.2 North America Codeine Tablet Market Size by Country
- 7.2.1 North America Codeine Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Codeine Tablet Market Size by Country (2021-2026)
- 7.2.3 North America Codeine Tablet Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Codeine Tablet Sales by Country
- 8.1.1 Europe Codeine Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Codeine Tablet Sales by Country (2021-2026)
- 8.1.3 Europe Codeine Tablet Sales Forecast by Country (2027-2032)
- 8.2 Europe Codeine Tablet Market Size by Country
- 8.2.1 Europe Codeine Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Codeine Tablet Market Size by Country (2021-2026)
- 8.2.3 Europe Codeine Tablet Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Codeine Tablet Sales by Country
- 9.1.1 Asia-Pacific Codeine Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Codeine Tablet Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Codeine Tablet Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Codeine Tablet Market Size by Country
- 9.2.1 Asia-Pacific Codeine Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Codeine Tablet Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Codeine Tablet Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Codeine Tablet Sales by Country
- 10.1.1 South America Codeine Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Codeine Tablet Sales by Country (2021-2026)
- 10.1.3 South America Codeine Tablet Sales Forecast by Country (2027-2032)
- 10.2 South America Codeine Tablet Market Size by Country
- 10.2.1 South America Codeine Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Codeine Tablet Market Size by Country (2021-2026)
- 10.2.3 South America Codeine Tablet Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Codeine Tablet Sales by Country
- 11.1.1 Middle East and Africa Codeine Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Codeine Tablet Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Codeine Tablet Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Codeine Tablet Market Size by Country
- 11.2.1 Middle East and Africa Codeine Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Codeine Tablet Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Codeine Tablet Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Codeine Tablet Value Chain Analysis
- 12.1.1 Codeine Tablet Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Codeine Tablet Production Mode & Process
- 12.2 Codeine Tablet Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Codeine Tablet Distributors
- 12.2.3 Codeine Tablet Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst